Robertson Catherine M, Allen R Todd, Pennock Andrew T, Bugbee William D, Amiel David
Department of Orthopaedic Surgery, University of California San Diego, La Jolla, CA, USA.
Clin Orthop Relat Res. 2006 Jan;442:260-6. doi: 10.1097/01.blo.0000187058.42820.39.
We identified changes in proapoptotic and extracellular matrix-related gene expression with prolonged storage of fresh osteochondral allografts using gene array analysis to better understand the process of graft degradation during storage. Six human distal femurs were obtained according to standard organ harvesting protocol and stored in serum-free allograft media. Each was examined at baseline (within 72 hours postmortem), 21 days (average time of implantation), and 35 days (maximum time to implantation) for proapoptotic and extracellular matrix-related gene expression using two 100-gene microarrays, cell viability using confocal microscopy, and proteoglycan synthesis via SO4 incorporation. We found numerous genes showing upregulation associated with increased storage time, including CD30, CD30 ligand, Fas, Fas ligand, tumor necrosis factor-alpha, and several caspases. Cell viability and proteoglycan synthesis also were significantly decreased with increased storage. Loss of chondrocytes via apoptosis is likely a key determinant of osteochondral allograft viability during storage, whereas extracellular matrix degeneration may occur at a later stage. These findings provide targets for future media modulation. Improved graft viability and the potential for lengthened storage periods through improved storage conditions may improve clinical outcomes and availability of fresh osteochondral allografts.
我们通过基因芯片分析确定了新鲜异体骨软骨移植体长期保存过程中促凋亡和细胞外基质相关基因表达的变化,以更好地了解保存期间移植体降解的过程。根据标准器官获取方案获取6例人类股骨远端,保存在无血清移植培养基中。使用两个100基因微阵列,在基线(死后72小时内)、21天(平均植入时间)和35天(最长植入时间)时检测促凋亡和细胞外基质相关基因表达,使用共聚焦显微镜检测细胞活力,并通过硫酸根掺入检测蛋白聚糖合成。我们发现许多基因的上调与保存时间延长有关,包括CD30、CD30配体、Fas、Fas配体、肿瘤坏死因子-α和几种半胱天冬酶。随着保存时间延长,细胞活力和蛋白聚糖合成也显著降低。凋亡导致软骨细胞丢失可能是异体骨软骨移植体保存期间存活的关键决定因素,而细胞外基质退变可能在后期发生。这些发现为未来的培养基调节提供了靶点。通过改善保存条件提高移植体活力和延长保存期的可能性,可能会改善新鲜异体骨软骨移植体的临床疗效和可用性。